Israel Englander Acumen Pharmaceuticals, Inc. Call Options Transaction History

Millennium Management LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2023 Aug 14, 2023	BUY	$3.59 - $6.59 $696,819 - $1.28 Million	194,100 New	194,100 $933,000
Q3 2022 Nov 14, 2022	BUY	$4.44 - $10.48 $288,600 - $681,200	65,000 New	65,000 $652,000

41.8M

57.7K

749K

Ticker ABOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,503,100
Market Cap $72.1M
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.